Abstract
Background
Inflammatory response is an important feature of acute coronary syndromes and myocardial infarction (MI). The prognostic value of proinflammatory cytokines in patients with acute MI complicated by cardiogenic shock is unknown.
Methods and results
In 41 patients admitted with acute MI (age 60 ± 11 years, six females, 19 Killip class IV) serial plasma concentration of tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6) and interleukin 1 receptor antagonist (IL-1Ra) were measured. Seven patients with cardiogenic shock (CS) developed a systemic inflammatory response syndrome (SIRS). Patients with CS—particularly those who developed SIRS—showed significantly higher cytokine levels than patients with uncomplicated MI. In patients with CS and SIRS peak levels of IL-1Ra were 223,973 pg/ml, IL-6 252.8 pg/ml and TNF-α 7.0 pg/ml. In CS without SIRS IL-1Ra levels were 19,988 pg/ml, IL-6 109.3 pg/ml and TNF-α 3.8 pg/ml. In uncomplicated MI peak IL-1Ra levels were 1,088 pg/ml, IL-6 34.1 pg/ml and TNF-α 2.6 pg/ml.
Conclusions
The inflammation-associated cytokines TNF-α, IL-6 and IL-1Ra are significantly elevated in patients with MI complicated by CS when compared to patients with uncomplicated MI. Among shock-patients IL-1Ra levels are promising diagnostic markers for early identification of patients developing SIRS, heralding a poor outcome.
Similar content being viewed by others
References
Akira S, Hirano T, Taga T et al. (1990) Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4:2860–2867
Arai KI, Lee F, Miyajima A et al. (1990) Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783–836
Biasucci LM (1996) Elevated Levels of Interleukin-6 in Unstable Angina. Circulation 94:874–877
Biasucci LM, Liuzzo G, Fantuzzi G et al. (1999) Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99:2079–2084
Cannon JG, Tompkins RG, Gelfand JA et al. (1990) Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 161:79–84
Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Int Med 119:771–778
Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503–508
Fischer E, Van Zee KJ, Marano MA et al. (1992) Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196–2200
Gabay C (2002) Cytokine inhibitors in the treatment of rheumatoid arthritis. Expert Opin Biol Ther 2:135–149
Garces K (2001) Anakinra: interleukin-1 receptor antagonist therapy for rheumatoid arthritis. Issues Emerg Health Technol 1–4
Ghezzi P, Dinarello CA, Bianchi M et al. (1991) Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 3:189–194
Granowitz EV, Santos AA, Poutsiaka DD et al. (1991) Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338:1423–1424
Hasdai D, Holmes DR Jr., Topol EJ et al. (1999) Frequency and clinical outcome of cardiogenic shock during acute myocardial infarction among patients receiving reteplase or alteplase. Results from GUSTO-III. Global Use of Strategies to Open Occluded Coronary Arteries. Eur Heart J 20:128–135
Hegewisch S, Weh HJ, Hossfeld DK (1990) TNF-induced cardiomyopathy. Lancet 335:294–295
Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A et al. (1999) Tumor necrosis factor-alpha: a mediator of disease progression in the failing human heart. Chest 115:1170–1174
Hirschl MM, Gwechenberger M, Binder T et al. (1996) Assessment of myocardial injury by serum tumour necrosis factor alpha measurements in acute myocardial infarction. Eur Heart J 17:1852–1859
Hochman JS, Sleeper LA, Webb JG et al. (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341:625–634
Hochman JS, Sleeper LA, White HD et al. (2001) One-year survival following early revascularization for cardiogenic shock. JAMA 285:190–192
Kohsaka S, Menon V, Lowe AM et al. (2005) Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165:1643–1650
Levine B, Kalman J, Mayer L et al. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241
Mantovani A, Bussolino F, Dejana E (1992) Cytokine regulation of endothelial cell function. FASEB J 6:2591–2599
Millar AB, Foley NM, Singer M et al. (1989) Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 2:712–714
Moser R, Schleiffenbaum B, Groscurth P et al. (1989) Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest 83:444–455
Neumann FJ, Ott I, Gawaz M et al. (1995) Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92:748–755
Schuler J, Maier B, Behrens S et al. (2006) Present treatment of acute myocardial infarction in patients over 75 years. Clin Res Cardiol 95:360–367
Shigematsu S (1998) Therapeutic potential of interleukin-1 receptor antagonist in inflammatory bowel disease. Kurume Med J 45:175–179
Sturk A, Hack CE, Aarden LA et al. (1992) Interleukin-6 release and the acute-phase reaction in patients with acute myocardial infarction: a pilot study. J Lab Clin Med 119:574–579
Suffredini AF, Fromm RE, Parker MM et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280–287
Torre-Amione G, Kapadia S, Lee J et al. (1996) Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation 93:704–711
Vaddi K (1994) Increased secretion of tumor necrosis factor-α and interferon-γ by mononuclear leukocytes in patients with ischemic heart disease. Circulation 90:694–699
van der Poll T, Levi M, Hack CE et al. (1994) Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179:1253–1259
Werra Id. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factro receptors, and procalcitonin concentrations: compaision in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607–613
Acknowledgments
We would like to acknowledge the efforts of the entire team of the central laboratory. The study would not have been possible without the dedicated efforts of the laboratory technicians and the ICU-staff of the Triemli Hospital.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Debrunner, M., Schuiki, E., Minder, E. et al. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol 97, 298–305 (2008). https://doi.org/10.1007/s00392-007-0626-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-007-0626-5